Venetoclax + hypomethylating agents combined with dose-adjusted HAG for relapsed/refractory acute myeloid leukemia: Two case reports

RATIONALE: Some acute myeloid leukemia (AML) patients are unresponsive to treatment or have remission followed by worsening of disease (known as relapsed/refractory AML [R/RAML]) after standardized treatment. The CAG/HAG regimen is not often used clinically because heterogenous patient responses, re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongxia, Bai, Junjun, Pei, Zhixin, Zhang, Bei, Wang, Junjie, Lian, Xingli, Song, Qinglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676608/
https://www.ncbi.nlm.nih.gov/pubmed/33217852
http://dx.doi.org/10.1097/MD.0000000000023265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676608/
https://www.ncbi.nlm.nih.gov/pubmed/33217852
http://dx.doi.org/10.1097/MD.0000000000023265

Ejemplares similares